Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma-Reference-Cited by-同舟云学术

Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma

Published:2020-04-23 Issue:9 Volume:30 Page:5021-5028
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Dormieux Alison,Mezquita Laura,Cournede Paul Henry,Remon Jordi,Tazdait Melodie,Lacroix Ludovic,Rouleau Etienne,Adam Julien,Bluthgen Maria-Virginia,Facchinetti Francesco,Tselikas Lambros,Aboubakar Frank,Naltet Charles,Lavaud Pernelle,Gazzah Anas,Le Pechoux Cécile,Lassau Nathalie,Balleyguier Corinne,Planchard David,Besse Benjamin,Caramella Caroline

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-020-06784-y.pdf

Reference39 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

2. INCA - Les cancers en France [Internet]. [cited 2019 Mar 27]. Available from: https://www.e-cancer.fr/ressources/cancers_en_france/

3. Locher C, Debieuvre D, Coëtmeur D et al (2013) Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies. Lung Cancer 81(1):32–38

4. Cancer of the Lung and Bronchus - Cancer Stat Facts [Internet]. SEER. [cited 2019 Aug 22]. Available from: https://seer.cancer.gov/statfacts/html/lungb.html

5. Barlesi F, Mazieres J, Merlio J-P et al (2016) Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet 387(10026):1415–1426

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a nomogram model based on biomarkers for liver metastasis in non‐small cell lung cancer;Thoracic Cancer;2024-08-04

2. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer: a retrospective, multicenter study;2024-02-15

3. Local control strategies for management of NSCLC with oligoprogressive disease;Cancer Treatment Reviews;2023-11

4. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer;2023-09-15

5. Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer;Molecular Carcinogenesis;2023-04-17